Cancer-fighting AI developer Lunit has picked up a $61m pre-IPO financing round from investors including HealthQuest Capital and Casdin Capital. The post Anti-cancer AI tools developer Lunit gets $61m pre-IPO funding round first appeared on AltAssets
French biotech company AlgoTherapeutix has raised €12m in a Series A round led by Bpifrance through its InnoBio 2 fund alongside co-investor Omnes.
Blood and bone marrow cancer treatment developer Priothera Limited has picked up a €30m Series A investment round from a clutch of venture capital firms.
SV Health Investors has hit a $265m final close for its first dedicated biotech fundraise.
